Lumigenex is a nanotechnology-driven provider of POCT products to the clinical laboratories, doctor offices and At-home tests. It specializes in developing and manufacturing of quantitative POCT readers and diagnostic kits based on its proprietary TRFIA platform to detect CVS diseases, women's health, and infectious diseases including many COVID-19 rapid tests. We also offer dry chemistry analyzers and reagents to manage chronic diseases by measuring lipids, glucose, creatinine and uric acids.